Candriam S.C.A.
Institutional investor · Portfolio as of Q2 2024
Top Holdings687 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
MICROSOFT CORP | 2.5M | $1.1B | 6.7% | $191.13 | +131.25% | 22 qtrssince 2019-Q1 | Decreased 0 |
NVIDIA CORP | 6.9M | $848.6M | 5.1% | $114.16 | +8.17% | 22 qtrssince 2019-Q1 | Increased 100 |
APPLE INC | 3.6M | $748.9M | 4.5% | $122.20 | +70.72% | 22 qtrssince 2019-Q1 | Decreased 0 |
ALPHABET INC-CL A | 3.1M | $556.3M | 3.4% | $99.28 | +82.31% | 22 qtrssince 2019-Q1 | Decreased 0 |
ELI LILLY & CO | 485,616 | $439.6M | 2.7% | $420.85 | +111.86% | 22 qtrssince 2019-Q1 | Increased 63 |
MERCK & CO. INC. | 2.4M | $294.7M | 1.8% | $71.01 | +65.58% | 22 qtrssince 2019-Q1 | Decreased 0 |
AMAZON.COM INC | 1.5M | $290.1M | 1.8% | $128.87 | +49.96% | 22 qtrssince 2019-Q1 | Increased 58 |
THERMO FISHER SCIENTIFIC INC | 431,658 | $238.7M | 1.4% | $426.91 | +28.90% | 22 qtrssince 2019-Q1 | Increased 49 |
UNITEDHEALTH GROUP INC | 450,366 | $229.3M | 1.4% | $382.60 | +28.95% | 22 qtrssince 2019-Q1 | Increased 55 |
VISA INC-CLASS A SHARES | 831,372 | $218.2M | 1.3% | $212.12 | +21.66% | 22 qtrssince 2019-Q1 | Increased 51 |
REGENERON PHARMACEUTICALS | 200,708 | $210.9M | 1.3% | $491.40 | +112.71% | 22 qtrssince 2019-Q1 | Decreased 0 |
AMGEN INC | 610,168 | $190.6M | 1.2% | $190.70 | +54.09% | 22 qtrssince 2019-Q1 | Decreased 0 |
PROCTER & GAMBLE CO/THE | 1.1M | $183.7M | 1.1% | $115.18 | +34.85% | 22 qtrssince 2019-Q1 | Increased 51 |
MASTERCARD INC - A | 413,193 | $182.3M | 1.1% | $327.51 | +33.35% | 22 qtrssince 2019-Q1 | Increased 50 |
ALPHABET INC-CL C | 951,984 | $174.6M | 1.1% | $96.77 | +88.34% | 22 qtrssince 2019-Q1 | Increased 48 |
APPLIED MATERIALS INC | 676,556 | $159.7M | 1.0% | $151.92 | +52.77% | 22 qtrssince 2019-Q1 | Increased 46 |
VERTEX PHARMACEUTICALS INC | 328,271 | $153.9M | 0.9% | $231.39 | +102.56% | 22 qtrssince 2019-Q1 | Decreased 0 |
BROADCOM INC | 94,176 | $151.2M | 0.9% | $46.44 | +240.59% | 22 qtrssince 2019-Q1 | Increased 44 |
TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/ | 803,095 | $139.6M | 0.8% | $89.95 | +89.36% | 22 qtrssince 2019-Q1 | Increased 43 |
GILEAD SCIENCES INC | 2M | $138.6M | 0.8% | $59.58 | +10.06% | 22 qtrssince 2019-Q1 | Decreased 0 |
Candriam S.C.A. manages $16.5B across 687 positions as of Q2 2024. Top holdings: MSFT (6.7%), NVDA (5.1%), AAPL (4.5%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 2/5.0.
Active quarter - 53 new positions, 61 exits, 341 increased. Top move: NVDA (INCREASED, conviction 100). Portfolio: $16.5B across 687 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer